Capital Bank & Trust Co - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Bank & Trust Co ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2020$207,000
-40.5%
8,4000.0%0.00%
-40.0%
Q3 2020$348,000
-13.4%
8,4000.0%0.01%
-16.7%
Q2 2020$402,000
-24.0%
8,4000.0%0.01%
-33.3%
Q1 2020$529,000
-49.2%
8,4000.0%0.01%
-30.8%
Q4 2019$1,041,000
+86.9%
8,4000.0%0.01%
+62.5%
Q3 2019$557,000
-16.6%
8,4000.0%0.01%0.0%
Q2 2019$668,0008,4000.01%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders